<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47065">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02099227</url>
  </required_header>
  <id_info>
    <org_study_id>AHC IRB 5577</org_study_id>
    <nct_id>NCT02099227</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections</brief_title>
  <official_title>Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samuel Lam</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Emergency Physicians</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Toronto Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newark Beth Israel Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital &amp; Research Center Oakland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maimonides Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Advocate Health Care</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the effect of Point-of-Care Ultrasound (POCUS) management guidance on pediatric
      skin and soft tissue infections treatment failure rate, as well as emergency department
      process outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>treatment failure rate</measure>
    <time_frame>7-10days</time_frame>
    <safety_issue>No</safety_issue>
    <description>unscheduled return visits need for subsequent procedural intervention need for subsequent admission change in therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>emergency department process outcome</measure>
    <time_frame>7-10days</time_frame>
    <safety_issue>No</safety_issue>
    <description>emergency department (ED) length of stay, need for ED procedural sedation use of alternative imaging in ED</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Soft Tissue Infection</condition>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <description>those who received point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Ultrasound</arm_group_label>
    <description>those who did not receive point-of-care ultrasound as part of their emergency department evaluation/ treatment for suspected soft tissue infections</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        children presenting to participating pediatric emergency departments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history and examination findings consistent with possible abscess or cellulitis per
             the treating clinician.

          -  minimal lesion diameter for inclusion is 1cm.

        Exclusion Criteria:

          -  suspected soft tissue infections involving or near mucosal membranes (e.g.
             perirectal, peritonsillar, vulvovaginal areas)

          -  facial lesions

          -  paronychia or felon

          -  parent or patient refusal of consent

          -  unsuitable subjects deemed by treating clinicians.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Lam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Advocate Christ Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samuel Lam, MD</last_name>
    <phone>708 684 5354</phone>
    <email>hiufungsamuel.lam@advocatehealth.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Lam, MD</last_name>
      <phone>708-684-5354</phone>
      <email>hiufungsamuel.lam@advocatehealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Kathleen Hesse, RN</last_name>
      <phone>708 684 3450</phone>
    </contact_backup>
    <investigator>
      <last_name>Samuel Lam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>March 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Advocate Health Care</investigator_affiliation>
    <investigator_full_name>Samuel Lam</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>soft tissue infections</keyword>
  <keyword>ultrasonography</keyword>
  <keyword>effectiveness</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Soft Tissue Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
